glp 1 medullary thyroid cancer Can a Glucagon-like peptide-1 (GLP-1) receptor agonist be prescribed to a patient with a history of non-medullary cancer? Glucagon-like peptide-1 medicines and cancer

These include unexplained weight loss beyond expected therapeutic effects, persistent fever, night sweats, shortness of breath, chest pain, palpitations, or changes in mood such as low mood or anxiety

We identified 7,511 individuals who used GLP-1 RAs and did not undergo dialysis or die within 3 months post-discharge were enrolled as the GLP-1 RAs users group (Table 1)

Most common long-term side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation

Step 3 Nurse arrives

Many BCBS affiliates cover Zepbound with prior authorization, but some like BCBS of Michigan have dropped GLP-1 weight loss drug coverage entirely

It is always best to consult with your healthcare provider before starting GLP, especially if you are taking other medications or have any existing health conditions